Retraction Note: Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma
- PMID: 40781159
- DOI: 10.1038/s41388-025-03526-6
Retraction Note: Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma
Retraction of
-
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma.Oncogene. 2024 May;43(20):1534-1548. doi: 10.1038/s41388-024-03013-4. Epub 2024 Mar 28. Oncogene. 2024. Retraction in: Oncogene. 2025 Aug 8. doi: 10.1038/s41388-025-03526-6. PMID: 38548966 Retracted.
Similar articles
-
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma.Oncogene. 2024 May;43(20):1534-1548. doi: 10.1038/s41388-024-03013-4. Epub 2024 Mar 28. Oncogene. 2024. Retraction in: Oncogene. 2025 Aug 8. doi: 10.1038/s41388-025-03526-6. PMID: 38548966 Retracted.
-
Photothermal therapy combined with a STING agonist induces pyroptosis, and gasdermin D could be a new biomarker for guiding the treatment of pancreatic cancer.J Transl Med. 2025 Mar 4;23(1):271. doi: 10.1186/s12967-025-06247-2. J Transl Med. 2025. PMID: 40038726 Free PMC article.
-
Synergistic Provoking of Pyroptosis and STING Pathway by Multifunctional Manganese-Polydopamine Nano-Immunomodulator for Enhanced Renal Cell Carcinoma Immunotherapy.Adv Healthc Mater. 2025 Jun;14(16):e2500141. doi: 10.1002/adhm.202500141. Epub 2025 May 20. Adv Healthc Mater. 2025. PMID: 40394938
-
NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy: Pathogenic Mechanisms and Therapeutic Targets.J Inflamm Res. 2025 Jun 25;18:8399-8418. doi: 10.2147/JIR.S524246. eCollection 2025. J Inflamm Res. 2025. PMID: 40585041 Free PMC article. Review.
-
Review: the role of GSDMD in sepsis.Inflamm Res. 2022 Nov;71(10-11):1191-1202. doi: 10.1007/s00011-022-01624-9. Epub 2022 Aug 15. Inflamm Res. 2022. PMID: 35969260 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials